Loading clinical trials...
Loading clinical trials...
TUMOSPEC is a national family study designed to measure the relative and absolute risk of cancer for carriers of deleterious mutations to these "new" breast cancer (BC) susceptibility genes. Index cas...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
UNICANCER
Collaborators
NCT04541381 · Gastrointestinal Cancer, Head and Neck Cancer, and more
NCT06043817 · Non-Small Cell Lung Cancer, NSCLC, and more
NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more
NCT07434843 · SDH Gene Mutation, Gastrointestinal Stromal Tumor
NCT06636162 · Glioma, Malignant, IDH Mutation
Gustave Roussy
Paris
Institut Curie - PIGE
Paris
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions